<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://safernicotine.wiki/mediawiki/index.php?action=history&amp;feed=atom&amp;title=Translations%3AENDS_Toxicity_%2F_Carcinogenic%2F24%2Fen</id>
	<title>Translations:ENDS Toxicity / Carcinogenic/24/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://safernicotine.wiki/mediawiki/index.php?action=history&amp;feed=atom&amp;title=Translations%3AENDS_Toxicity_%2F_Carcinogenic%2F24%2Fen"/>
	<link rel="alternate" type="text/html" href="https://safernicotine.wiki/mediawiki/index.php?title=Translations:ENDS_Toxicity_/_Carcinogenic/24/en&amp;action=history"/>
	<updated>2026-04-16T21:13:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://safernicotine.wiki/mediawiki/index.php?title=Translations:ENDS_Toxicity_/_Carcinogenic/24/en&amp;diff=11717&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://safernicotine.wiki/mediawiki/index.php?title=Translations:ENDS_Toxicity_/_Carcinogenic/24/en&amp;diff=11717&amp;oldid=prev"/>
		<updated>2021-11-20T01:16:47Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;*Results from this study suggest that e‐cigarettes may have reduced tumor promoter activity compared to conventional cigarettes and therefore may provide a safer alternative to cigarettes.&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435921/pdf/EM-58-190.pdf PDF Version]&lt;br /&gt;
*Citation: Breheny D, Oke O, Pant K, Gaça M. Comparative tumor promotion assessment of e-cigarette and cigarettes using the in vitro Bhas 42 cell transformation assay. Environ Mol Mutagen. 2017 May;58(4):190-198. doi: 10.1002/em.22091. PMID: 28444993; PMCID: PMC5435921.&lt;br /&gt;
*Acknowledgements: The authors are employees of British American Tobacco or BioReliance Corporation. BioReliance conducted all experimental work and were funded by British American Tobacco. Nicoventures, UK, is a wholly‐owned subsidiary of British American Tobacco.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>